Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - TOTAL LIABILITIES
Total Liabilities VRDN - Viridian Therapeutics, Inc.
48.4 M
LAST VALUE
73.97%
2 YEAR CAGR
26.74%
5 YEAR CAGR
40.23%
10 YEAR CAGR